News and Stories About PanCAN grantee

After losing her mom and uncle to pancreatic cancer, Nancy made an impact by donating to PanCAN to fund Ingunn’s early-career research […]

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like to introduce you to each grantee to […]
READ MORE

The Pancreatic Cancer Action Network’s (PanCAN) Annual Scientific Summit may have looked different this year, but some things stayed the […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: May is National Cancer Research Month, which provides an opportunity to highlight the incredible scientific and clinical research […]
READ MORE

All the way across the country from one another, two pancreatic cancer researchers made similar discoveries in their labs. Rushika […]
READ MORE

Pancreatic Cancer Action Network (PanCAN) research grantee Kenneth Olive, PhD, is dedicated to keeping his lab as connected as possible […]
READ MORE

New research suggests that pancreatic tumors can be classified into two broad categories – and this information can help guide […]
READ MORE

The goal of cancer treatment is to identify – and attack – vulnerabilities that make cancer cells different from healthy […]
READ MORE

We are extremely sad to share that Pancreatic Cancer Action Network (PanCAN) research grant recipient David Boothman, PhD, died on […]
READ MORE

When immunology expert Ingunn Stromnes, PhD, assistant professor of microbiology and immunology at the University of Minnesota, unexpectedly discovered a […]
READ MORE

A new study out today in Cell links tumor bacteria to long-term pancreatic cancer survival. Examining tumor samples from pancreatic […]
READ MORE

Editor’s note: We recently announced the recipients of our 2019 research grants, awarded through a competitive, peer-review process. Now we’d […]
READ MORE

Editor’s note: We recently announced the recipients of our 2019 research grants, awarded through a competitive, peer-review process. Now we’d […]
READ MORE

Editor’s note: We recently announced the recipients of our 2019 research grants, awarded through a competitive, peer-review process. Now we’d […]
READ MORE

Editor’s note: We recently announced the recipients of our 2019 research grants, awarded through a competitive, peer-review process. Now we’d […]
READ MORE

Dedicated to improving patient outcomes, the Pancreatic Cancer Action Network (PanCAN) has announced the recipients of its 2019 research grants. […]
READ MORE

How does someone trained in spin physics – the study of the “magnetic moment” of elementary particles – apply that […]
READ MORE

A new treatment combination – combining chemotherapy and radiation therapy with a common blood pressure drug – has shown promise […]
READ MORE

Editor’s note: May is National Cancer Research Month, and we recently had the opportunity to speak with two leading pancreatic […]
READ MORE

Nearly $178 million was invested in pancreatic cancer research by the National Cancer Institute (NCI) in 2017 – a 17 […]
READ MORE

“I’ve been attending the American Association for Cancer Research (AACR) annual meetings for several years, and this year’s conference was […]
READ MORE

A study published in Nature today describes how mutant KRAS impacts pancreatic cancer cells’ ability to gather nutrients – and […]
READ MORE

The largest-ever molecular analysis of pancreatic cancer tissue samples – from more than 3,500 patients – revealed some new clues […]
READ MORE

New donor-funded research published today in the journal Nature describes signals that prepare the liver in advance for pancreatic cancer […]
READ MORE

Editor’s note: Hear directly from pancreatic cancer researcher Kirsten Bryant, PhD, and Julie Fleshman, president and CEO of the Pancreatic […]
READ MORE

Even before certain cells of the pancreas become cancer, changes occur in their ability to break down nutrients, according to […]
READ MORE

Editor’s note: On July 25, 2008, 10 years ago today, professor Randy Pausch, PhD, of “The Last Lecture” fame, died […]
READ MORE

This year, the Pancreatic Cancer Action Network (PanCAN) awarded eight prestigious research grants to scientists and clinicians in the United […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) recently announced this year’s recipients of prestigious research grants. Funding decisions were made by […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) announces the funding of eight new, innovative pancreatic cancer research projects through its Research […]
READ MORE

Every pancreatic tumor is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends molecular profiling of your tumor to help […]
READ MORE

If you had asked Jason Doles, PhD, five years ago where he anticipated he’d be today, he would not have […]
READ MORE

The theme for this year’s American Association for Cancer Research (AACR) Annual Meeting, which took place earlier this week in […]
READ MORE

Pancreatic Cancer Action Network (PanCAN) grantee Dung Le, MD, provided commentary in the April 2018 issue of Smithsonian Magazine. The […]
READ MORE

Scientists have known for quite some time that pancreatic tumors are surrounded by an especially dense and complex “stroma,” a […]
READ MORE

About 95 percent of pancreatic cancer cases – and around 30 percent of all human cancers – have a mutation […]
READ MORE

Both Wantong Yao, MD, PhD, and Haoqiang Ying, MD, PhD, underwent medical training in China. They both became deeply interested […]
READ MORE

Paul E. Oberstein, MD, joins NYU Langone Health and its Perlmutter Cancer Center on March 1 as director of gastrointestinal […]
READ MORE

Two-time Pancreatic Cancer Action Network (PanCAN) research grant recipient, Timothy Wang, MD, set out to answer an unusual question: How […]
READ MORE

Editor’s note: Welcome to the second part of our 2017 research highlights recap (we’re pretty excited that it’s taking two […]
READ MORE

Editor’s note: This article is the first in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE

Pancreatic cancer researcher Kenneth Scott, PhD, associate professor of molecular and human genetics at Baylor College of Medicine, passed away […]
READ MORE

A multi-institutional research team, including Vinod Balachandran, MD, and Steven Leach, MD, set out to ask an important question: “What […]
READ MORE

Among the many genetic mutations and molecular alterations that can be found in pancreatic tumors, there are four that are […]
READ MORE

This Sunday, Oct. 15, tune-in to iHeart Radio Dallas’ “Sunday Morning Magazine” public affairs show featuring Pancreatic Cancer Action Network […]
READ MORE

In a forward-looking study of patients diagnosed with various types of cysts of the pancreas, researchers at the University of […]
READ MORE

Sometimes the most unexpected and unusual observations in the laboratory can lead to important results. Such was the case when […]
READ MORE

Back when he was a postdoctoral researcher, grantee Kazuki Sugahara, MD, PhD, found that a peptide, or small piece of […]
READ MORE

“This is a meeting like no other – and this is an organization like no other!” Thus began the Pancreatic […]
READ MORE

A Pancreatic Cancer Action Network Career Development Award in 2014 allowed David DeNardo, PhD, to ask and answer important questions […]
READ MORE

It’s not every day that you get to hear from a Pancreatic Cancer Action Network research grantee and a Pancreatic […]
READ MORE

The cleverly named The Cancer Genome Atlas project – abbreviated TCGA, in homage to the four base pairs that make […]
READ MORE

When Nada Kalaany, PhD, set out to establish an independent lab at Boston Children’s Hospital, she was determined to answer […]
READ MORE

Breakthrough Study by Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice Gene Responsible for Enhanced […]
READ MORE

Researchers at the University of Nebraska Medical Center (UNMC) are making headlines and spreading hope thanks to their findings published […]
READ MORE

2017 Grant Recipients and Pancreatic Cancer Survivor Featured on KATU-TV in Portland, Ore. Last month, our organization awarded 17 grants […]
READ MORE

One of the biggest challenges faced by scientists trying to solve lingering mysteries about the biology of pancreatic cancer is […]
READ MORE

Did you read about The New York Times article featuring breakthrough gene therapy and its potential applications to pancreatic cancer? […]
READ MORE

Earlier this month, our organization awarded 17 grants to 21 researchers at 12 institutions across the country through our competitive […]
READ MORE

The chemotherapy gemcitabine is widely used to treat pancreatic cancer patients. However, many patients develop resistance to the drug, leading […]
READ MORE

How can treatments break through the stroma? The complex and dense “stroma” surrounding pancreatic cancer cells has been a major […]
READ MORE

What cells actually become pancreatic cancer? To help answer this question, the Pancreatic Cancer Action Network awarded Jennifer Bailey, PhD, […]
READ MORE

Last week, we shared the exciting news that an immunotherapy agent, Keytruda, was the first drug approved by the FDA […]
READ MORE

Finding out that you have a cyst on your pancreas is a terrifying moment of uncertainty. What are the chances […]
READ MORE

While missing teeth and poor dental health were previously believed to be associated with an increased risk of pancreatic cancer, […]
READ MORE

Editor’s note: This story was originally published in 2016, but we are sharing it again this month in celebration and […]
READ MORE

The saying, “Everything’s bigger in Texas,” holds true for our passionate pancreatic cancer community in Dallas-Fort Worth (DFW). Earlier today, […]
READ MORE

An all-star collaboration between three Pancreatic Cancer Action Network research grant recipients, representing three different institutions, has shown that immune […]
READ MORE

Thanks to the generosity of donors, we awarded our largest-ever grant of $2 million in 2016 to accelerate a large-scale […]
READ MORE

The Pancreatic Cancer Action Network’s state-of-the-art Know Your Tumor® precision medicine service offers molecular profiling to eligible patients. Molecular profiling […]
READ MORE

May is National Cancer Research Month! For National Cancer Research Month, we are highlighting some fantastic research advancements your support […]
READ MORE

May is National Cancer Research Month! For National Cancer Research Month, we are highlighting some fantastic research advancements your support […]
READ MORE

A novel peptide (small piece of protein) developed by a Pancreatic Cancer Action Network grantee was shown to benefit a […]
READ MORE

Last week, nearly 22,000 cancer researchers from around the world gathered in Washington, D.C., for the largest-ever American Association for […]
READ MORE

The more researchers analyze the interaction between pancreatic cancer cells and the patient’s immune system, the more complex the relationship […]
READ MORE

Grantees and scientific leadership celebrating at awards dinner On the evening of Tuesday, April 4, the Pancreatic Cancer Action Network (PanCAN), […]
READ MORE

As a risk factor, smoking is thought to contribute to about 20 percent of pancreatic cancer cases. Now, new research […]
READ MORE

On a recent Saturday morning, the Der and Cox labs at the University of North Carolina at Chapel Hill were […]
READ MORE

What would you do with $1 million to improve outcomes for pancreatic cancer patients? A diverse group of seven research […]
READ MORE

It’s not every day that more than 450 pancreatic cancer researchers get together to talk about key topics in the […]
READ MORE

We are delighted to report that our grantee, Brian Wolpin, MD, MPH, has been appointed Robert T. and Judith B. […]
READ MORE

Changes that cause a normal cell to become cancerous are often genetic in nature – mutations or altered expression of […]
READ MORE

Researchers and clinicians have spent decades trying to devise ways to stop the growth and aggressive properties of pancreatic cancer […]
READ MORE

In April 2016, Jiyoung Ahn, PhD, recipient of the 2012 The Daniel and Janet Mordecai – Career Development Award, presented […]
READ MORE

Our Annual Scientific Meeting took place August 18 – 21 in beautiful San Diego, bringing together research grant recipients, current […]
READ MORE

One of the reasons that pancreatic cancer is particularly challenging to clinicians is that the majority of cases are diagnosed […]
READ MORE

Pancreatic cancer recently moved from the fourth to the third leading cause of cancer-related death in the United States, and […]
READ MORE

On Thursday evening, May 12, the American Association for Cancer Research (AACR) Pancreatic Cancer Special Conference kicked off in beautiful […]
READ MORE

From April 16 to April 20, nearly 20,000 cancer researchers from around the world gathered in New Orleans for the […]
READ MORE

In an insightful study published in the major journal Cell Stem Cell, Timothy Wang, MD, together with his colleagues and […]
READ MORE

The discovery of a new mode of pancreatic cancer cell death may play an important role in cancer cells’ survival.

Preliminary results from an early-phase immunotherapy clinical trial suggest that an innovative treatment could be effective for patients with locally-advanced or borderline-resectable pancreatic cancer.